14th Annual Course Anaemia, Neutropenia, Thrombosis and Cancer

Oncology Meeting Resources

06 Mar - 07 Mar, Madrid, Spain

This course aimed to clarify issues related to anaemia, neutropenia, thrombocytopenia and thrombosis in the cancer patient, including older patients, and the optimal way of  preventing or treating these problems, including a review of  guidelines. It will also focus on aspects still unresolved in the treatment of  cancer treatment-associated anaemia like management of  iron.

Here, you will find the slides from the 2015 Annual Course Anaemia, Neutropenia, Thrombosis and Cancer. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Useful Link

Presenter Presentation title Session title
M. Aapro Updated Anaemia Guidelines: ASH NICE ESMO About Anaemia in 2015
R. Pettengell Role of EPOs in lymphoma (Hodgkin’s and non-Hodgkin’s) Beyond solid tumours
C. Falandry Use of G-CSF: recent results from French studies Neutropenia in Cancer Patients
Y. Beguin How to evaluate vitamin and iron deficiency in practice Iron and Cancer Patients
H. Link EORTC, German, NICE and other guidelines for neutropenia prevention and G-CSF usage. Where do we stand? Neutropenia in Cancer Patients
A. Hofmann Patient Blood Management Special Lectures
C. Ay Treatment of DVT and PE in cancer patients: what to do Platelets or Thrombosis
P. Gascon Safety update on EPOs in chemotherapy treated cancer patients About Anaemia in 2015
C. Falandry Implications of neutropenia in the elderly patient The elderly cancer patient: a SIOG session
M. Dicato New developments for Thrombocytopenia management Platelets or Thrombosis
H. Ludwig Management of iron deficiency in clinical practice Platelets or Thrombosis
M. Mandalà Thromboprophylaxis in ambulatory cancer patients: ESMO and other guidelines Platelets or Thrombosis
D. Schrijvers Pathophysiology and incidence of anaemia in cancer patients Anaemia in Cancer Patients
R. Stauder EPO and thrombopoietic agents in MDS The elderly cancer patient: a SIOG session
H. Ludwig Monitor G-CSF and other data: why should elderly patients receive G-CSF The elderly cancer patient: a SIOG session